HLA-DR antigen expression on melanoma metastases and the course of the disease

Melanoma cells freshly isolated from regional lymph node metastases of 59 stage II malignant melanoma patients were analyzed by indirect immunofluorescence staining with monoclonal antibody TAL 1B5, detecting the HLA-DR alpha chain. The expression of HLA-A,B,C antigens, using antibody W6/32, was als...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Immunology Immunotherapy 1989-05, Vol.30 (3), p.185-189
Main Authors: MUNZAROVA, M, ZEMANOVA, D, REJTHAR, A, MECHL, Z, KOLCOVA, V
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Dissemination
Female
HLA-DR Antigens - analysis
Humans
Macrophages - immunology
Male
Medical sciences
Melanoma - immunology
Middle Aged
Neoplasm Metastasis
Original
Prognosis
Tumor cell
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Melanoma cells freshly isolated from regional lymph node metastases of 59 stage II malignant melanoma patients were analyzed by indirect immunofluorescence staining with monoclonal antibody TAL 1B5, detecting the HLA-DR alpha chain. The expression of HLA-A,B,C antigens, using antibody W6/32, was also investigated in 45 of these cases. There were no substantial differences in the course of the disease with respect to the percentage of positive cells. In 13 malignant melanoma patients two to four simultaneous and/or successive metastases (both locoregional and distant-subcutaneous) were analysed for HLA-DR. With simultaneous metastases (7 cases) the percentage of HLA-DR-positive cells was mostly very similar, and in no case was there more than 25% variation. As to successive metastases (9 cases) the percentage of HLA-DR-positive cells remained practically unchanged or decreased during the course of the disease.
ISSN:0340-7004
1432-0851
DOI:10.1007/BF01669428